FDA restrictions on some antibiotics use in agriculture

An article in the New York Times (Jan 4, 2012) describes FDA plans to restrict use of cephalasporins in agriculture. These antibiotics are used to treat strep and bronchitis and by surgeons. But they are also used on animals, with the resultant meat consumption creating bacteria resistant to these antibiotics. Farmers may face higher costs but the greater good is served. How should the FDA balance these competing interests ? How much risk or evidence standard should be used to balance such supply chain impacts ?

About aviyer2010

This entry was posted in Collaboration, Operations Management, Supply Chain Issues, Sustainability and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s